How Do You Spell AFIBRINOGENEMIA?

Pronunciation: [ɐfˌɪbɹɪnə͡ʊd͡ʒnˈiːmi͡ə] (IPA)

Afibrinogenemia is a medical condition characterized by the absence of a protein called fibrinogen in the blood. It is a complex word with 7 syllables and can be broken down into three parts - "a", "fibrino-" and "-genemia". The "a" indicates the absence of fibrinogen, while "fibrino-" refers to the protein that is absent. The ending "-genemia" means "in the blood". The phonetic transcription for this word is /eɪ.ˌfaɪ.braɪ.nəʊ.ˈdʒɛ.ni.miə/. Correct spelling is important for medical professionals to ensure accurate diagnosis and treatment.

AFIBRINOGENEMIA Meaning and Definition

1. Afibrinogenemia is a rare inherited disorder characterized by the complete absence or severe deficiency of fibrinogen in the blood. Fibrinogen, also known as Factor I, is a crucial protein involved in blood clotting. It is produced in the liver and plays a vital role in the formation of blood clots, which help prevent excessive bleeding following an injury or surgery.

   Individuals with afibrinogenemia have a significantly increased risk of bleeding, as their blood lacks the necessary fibrinogen to form clots. This condition is caused by mutations in the FGA, FGB, or FGG genes, which are responsible for codes that produce fibrinogen chains. The inheritance pattern is typically autosomal recessive, meaning that a person must inherit two abnormal copies of the gene (one from each parent) to have the disorder.

   The symptoms of afibrinogenemia may manifest as spontaneous bleeding, particularly in the joints, muscles, or internal organs, after even minor trauma or surgery. Other common symptoms include excessive menstrual bleeding, nosebleeds, bruising, and prolonged bleeding after dental extractions. Diagnosis is usually confirmed through blood tests that measure fibrinogen levels.

   Treatment for afibrinogenemia revolves around replacing the missing fibrinogen. This is achieved through the administration of cryoprecipitate or purified fibrinogen concentrates derived from donated blood. Additionally, clotting factor replacement therapy may be required in cases of severe bleeding. Regular monitoring of fibrinogen levels is necessary to ensure appropriate dosing and prevent complications associated with bleeding or blood clotting. Genetic counseling is crucial for affected individuals and their families to understand the hereditary nature of the condition and make informed decisions about family planning.

Common Misspellings for AFIBRINOGENEMIA

• zfibrinogenemia
• sfibrinogenemia
• wfibrinogenemia
• qfibrinogenemia
• adibrinogenemia
• acibrinogenemia
• avibrinogenemia
• agibrinogenemia
• atibrinogenemia
• aribrinogenemia
• afubrinogenemia
• afjbrinogenemia
• afkbrinogenemia
• afobrinogenemia
• af9brinogenemia
• af8brinogenemia
• afivrinogenemia
• afinrinogenemia
• afihrinogenemia

Etymology of AFIBRINOGENEMIA

The word "afibrinogenemia" is derived from combining several different root words:

1. "A-" is a prefix indicating "absence" or "lack of".

2. "Fibrinogen" refers to a protein that is crucial for blood clotting. It is produced in the liver and converted into fibrin during the clotting process.

3. "-emia" is a suffix indicating "pertaining to blood" or "condition of the blood".

When combined, the word "afibrinogenemia" represents a medical condition characterized by the absence or severe deficiency of fibrinogen in the blood, leading to impaired blood clotting.

Plural form of AFIBRINOGENEMIA is AFIBRINOGENEMIAS